Pharvaris Ownership 2024 | Who Owns Pharvaris Now?
Institutional Ownership
1.34%
Insider Ownership
9.49%
Retail Ownership
89.17%
Institutional Holders
3.00
Pharvaris Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 13.99% | 4.45% | 7,531,252 | - | - | 141,587,538 | Jun 30, 2024 |
| FMR LLC | 9.67% | 0.01% | 5,205,656 | 12,672 | 0.24% | 97,866,333 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 7.98% | 54.23% | 4,293,854 | 255,012 | 6.31% | 80,724,455 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 7.97% | 34.83% | 4,289,304 | - | - | 80,638,915 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 6.79% | 0.26% | 3,653,310 | - | - | 68,682,228 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.31% | 4.07% | 3,395,606 | - | - | 63,837,393 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 6.14% | 6.82% | 3,303,381 | - | - | 62,103,563 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.36% | 2.32% | 1,810,175 | 85,175 | 4.94% | 34,031,290 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.21% | 1.88% | 1,725,000 | 556,970 | 47.68% | 32,430,000 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.72% | 1.59% | 1,466,460 | -245,000 | -14.32% | 27,569,448 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.60% | 0.44% | 1,397,279 | 335,687 | 31.62% | 26,268,845 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.67% | 0.52% | 900,000 | - | - | 16,920,000 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.48% | 3.35% | 797,600 | - | - | 14,994,880 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.41% | 0.43% | 756,931 | 4,007 | 0.53% | 14,230,303 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.12% | 0.59% | 601,534 | 16,862 | 2.88% | 11,308,839 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.09% | 0.00% | 585,271 | -172,644 | -22.78% | 11,004,000 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.75% | 1.03% | 403,265 | 10,388 | 2.64% | 7,581,382 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.74% | 0.66% | 399,430 | -2,471 | -0.61% | 7,509,284 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.16% | 0.00% | 85,816 | -26,800 | -23.80% | 1,613,341 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.11% | 0.00% | 61,470 | 30,354 | 97.55% | 1,155,636 | Jun 30, 2024 |
Pharvaris's largest institutional shareholder is GENERAL ATLANTIC, L.P., holding 13.99% of the company's total share outstanding, currently valued at $141.59M. The top 10 institutional shareholders own together 68.15% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, LLC | 7.98% | 54.23% | 4,293,854 | 255,012 | 6.31% | 80,724,455 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 7.97% | 34.83% | 4,289,304 | - | - | 80,638,915 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 6.14% | 6.82% | 3,303,381 | - | - | 62,103,563 | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 13.99% | 4.45% | 7,531,252 | - | - | 141,587,538 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.31% | 4.07% | 3,395,606 | - | - | 63,837,393 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.48% | 3.35% | 797,600 | - | - | 14,994,880 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.36% | 2.32% | 1,810,175 | 85,175 | 4.94% | 34,031,290 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.21% | 1.88% | 1,725,000 | 556,970 | 47.68% | 32,430,000 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.72% | 1.59% | 1,466,460 | -245,000 | -14.32% | 27,569,448 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.75% | 1.03% | 403,265 | 10,388 | 2.64% | 7,581,382 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.74% | 0.66% | 399,430 | -2,471 | -0.61% | 7,509,284 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.12% | 0.59% | 601,534 | 16,862 | 2.88% | 11,308,839 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.67% | 0.52% | 900,000 | - | - | 16,920,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.60% | 0.44% | 1,397,279 | 335,687 | 31.62% | 26,268,845 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.41% | 0.43% | 756,931 | 4,007 | 0.53% | 14,230,303 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.06% | 0.39% | 34,328 | 34,328 | 100.00% | 645,366 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 6.79% | 0.26% | 3,653,310 | - | - | 68,682,228 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.03% | 0.12% | 16,750 | - | - | 314,900 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.05% | 5,001 | 5,001 | 100.00% | 94,019 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.03% | 0.02% | 15,883 | 15,883 | 100.00% | 298,600 | Jun 30, 2024 |
The largest Pharvaris shareholder by % of total assets is FORESITE CAPITAL MANAGEMENT IV, LLC. The company owns 4.29M shares of Pharvaris (PHVS), representing 54.23% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 3.21% | 1.88% | 1,725,000 | 556,970 | 47.68% | 32,430,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.60% | 0.44% | 1,397,279 | 335,687 | 31.62% | 26,268,845 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 7.98% | 54.23% | 4,293,854 | 255,012 | 6.31% | 80,724,455 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.36% | 2.32% | 1,810,175 | 85,175 | 4.94% | 34,031,290 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.06% | 0.39% | 34,328 | 34,328 | 100.00% | 645,366 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.11% | 0.00% | 61,470 | 30,354 | 97.55% | 1,155,636 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.07% | 0.00% | 38,945 | 18,418 | 89.73% | 732,166 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.12% | 0.59% | 601,534 | 16,862 | 2.88% | 11,308,839 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.03% | 0.02% | 15,883 | 15,883 | 100.00% | 298,600 | Jun 30, 2024 |
| FMR LLC | 9.67% | 0.01% | 5,205,656 | 12,672 | 0.24% | 97,866,333 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.75% | 1.03% | 403,265 | 10,388 | 2.64% | 7,581,382 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.05% | 5,001 | 5,001 | 100.00% | 94,019 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.41% | 0.43% | 756,931 | 4,007 | 0.53% | 14,230,303 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | 700 | 100.00% | 13,160 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 167 | 167 | 100.00% | 3,140 | Jun 30, 2024 |
| BLACKROCK INC. | 0.00% | - | 2,268 | - | - | 42,638 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | 0.00% | 31,224 | - | - | 587,011 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.10% | 0.00% | 55,078 | - | - | 1,035,466 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.01% | 2,000 | - | - | 37,600 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.03% | 0.12% | 16,750 | - | - | 314,900 | Jun 30, 2024 |
As of Jun 30 2024, Pharvaris's largest institutional buyer is NOVO HOLDINGS A/S. The company purchased 556.97K stocks of PHVS, valued at $32.43M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 2.72% | 1.59% | 1,466,460 | -245,000 | -14.32% | 27,569,448 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.09% | 0.00% | 585,271 | -172,644 | -22.78% | 11,004,000 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.09% | 0.00% | 48,768 | -48,414 | -49.82% | 916,838 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -30,138 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.16% | 0.00% | 85,816 | -26,800 | -23.80% | 1,613,341 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -20,018 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -11,700 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.10% | 0.00% | 51,168 | -7,001 | -12.04% | 961,958 | Jun 30, 2024 |
| MORGAN STANLEY | 0.04% | - | 23,296 | -5,745 | -19.78% | 437,965 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -3,150 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.74% | 0.66% | 399,430 | -2,471 | -0.61% | 7,509,284 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 6,121 | -1,687 | -21.61% | 115,075 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 7.97% | 34.83% | 4,289,304 | - | - | 80,638,915 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 6.14% | 6.82% | 3,303,381 | - | - | 62,103,563 | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 13.99% | 4.45% | 7,531,252 | - | - | 141,587,538 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.31% | 4.07% | 3,395,606 | - | - | 63,837,393 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.48% | 3.35% | 797,600 | - | - | 14,994,880 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.67% | 0.52% | 900,000 | - | - | 16,920,000 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 6.79% | 0.26% | 3,653,310 | - | - | 68,682,228 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.03% | 0.12% | 16,750 | - | - | 314,900 | Jun 30, 2024 |
As of Jun 30 2024, Pharvaris's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -0.24M shares of PHVS, valued at $27.57M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HEALTHINVEST PARTNERS AB | 0.06% | 0.39% | 34,328 | 34,328 | 100.00% | 645,366 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.03% | 0.02% | 15,883 | 15,883 | 100.00% | 298,600 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.05% | 5,001 | 5,001 | 100.00% | 94,019 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | 700 | 100.00% | 13,160 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 167 | 167 | 100.00% | 3,140 | Jun 30, 2024 |
Pharvaris's largest new institutional shareholder by number of shares is HEALTHINVEST PARTNERS AB, purchased 34.33K shares, valued at $645.37K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -30,138 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -20,018 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -11,700 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -3,150 | -100.00% | - | Jun 30, 2024 |
Pharvaris's largest sold out institutional shareholder by shares sold is QUBE RESEARCH & TECHNOLOGIES LTD, sold -30.14K shares, valued at -, as of undefined.
Pharvaris Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 0.00% | 450,251 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 14,671 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 114 | 60 | 111.11% | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 14,652 | 14,652 | - | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 82 | 82 | - | Jan 31, 2024 |
Pharvaris's largest mutual fund holder by % of total assets is "MUTUAL FUND SERIES TRUST", owning 450.25K shares, compromising 0.00% of its total assets.
Pharvaris Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -91.43% |
| 31 Mar, 24 | 35 | -2.78% |
| 31 Dec, 23 | 36 | 71.43% |
| 30 Sep, 23 | 21 | - |
| 30 Jun, 23 | 21 | - |
| 31 Mar, 23 | 21 | -16.00% |
| 31 Dec, 22 | 25 | 19.05% |
| 30 Sep, 22 | 21 | 5.00% |
| 30 Jun, 22 | 20 | -9.09% |
| 31 Mar, 22 | 22 | - |
| 31 Dec, 21 | 22 | -12.00% |
| 30 Sep, 21 | 25 | -10.71% |
| 30 Jun, 21 | 28 | -15.15% |
| 31 Mar, 21 | 33 | - |
As of 30 Jun 24, 3 institutions are holding Pharvaris's shares, representing a decrease of -91.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 718,574 | -98.31% |
| 31 Mar, 24 | 42,425,740 | 4.12% |
| 31 Dec, 23 | 40,745,703 | 40.18% |
| 30 Sep, 23 | 29,067,102 | 0.53% |
| 30 Jun, 23 | 28,913,752 | 32.74% |
| 31 Mar, 23 | 21,781,494 | 2.25% |
| 31 Dec, 22 | 21,301,855 | -4.54% |
| 30 Sep, 22 | 22,314,956 | -0.17% |
| 30 Jun, 22 | 22,353,338 | 3.08% |
| 31 Mar, 22 | 21,685,388 | 0.18% |
| 31 Dec, 21 | 21,647,018 | 0.07% |
| 30 Sep, 21 | 21,631,651 | -1.66% |
| 30 Jun, 21 | 21,995,815 | -0.13% |
| 31 Mar, 21 | 22,025,122 | - |
Pharvaris (PHVS) has 718.57K shares outstanding as of 30 Jun 24, down -98.31% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.34% | 0.02% |
| 31 Mar, 24 | 81.14% | 0.82% |
| 31 Dec, 23 | 99.60% | 1.96% |
| 30 Sep, 23 | 71.20% | 0.97% |
| 30 Jun, 23 | 85.48% | 2.06% |
| 31 Mar, 23 | 64.40% | 1.60% |
| 31 Dec, 22 | 63.42% | 1.45% |
| 30 Sep, 22 | 66.05% | 1.49% |
| 30 Jun, 22 | 66.56% | 1.55% |
| 31 Mar, 22 | 65.44% | 1.53% |
| 31 Dec, 21 | 65.33% | 0.76% |
| 30 Sep, 21 | 92.91% | 0.50% |
| 30 Jun, 21 | 136.16% | 0.23% |
| 31 Mar, 21 | 241.91% | - |
As of 30 Jun 24, Pharvaris is held by 1.34% institutional shareholders, representing a 0.02% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -94.44% |
| 31 Mar, 24 | 18 | -40.00% |
| 31 Dec, 23 | 30 | 233.33% |
| 30 Sep, 23 | 9 | -18.18% |
| 30 Jun, 23 | 11 | 120.00% |
| 31 Mar, 23 | 5 | -64.29% |
| 31 Dec, 22 | 14 | 75.00% |
| 30 Sep, 22 | 8 | - |
| 30 Jun, 22 | 8 | 33.33% |
| 31 Mar, 22 | 6 | -14.29% |
| 31 Dec, 21 | 7 | -12.50% |
| 30 Sep, 21 | 8 | -27.27% |
| 30 Jun, 21 | 11 | -66.67% |
| 31 Mar, 21 | 33 | - |
1 institutional shareholders have increased their position in PHVS stock as of 30 Jun 24 compared to 18 in the previous quarter (a -94.44% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -88.89% |
| 31 Mar, 24 | 9 | 125.00% |
| 31 Dec, 23 | 4 | -33.33% |
| 30 Sep, 23 | 6 | 50.00% |
| 30 Jun, 23 | 4 | -20.00% |
| 31 Mar, 23 | 5 | 66.67% |
| 31 Dec, 22 | 3 | -40.00% |
| 30 Sep, 22 | 5 | -16.67% |
| 30 Jun, 22 | 6 | -25.00% |
| 31 Mar, 22 | 8 | 33.33% |
| 31 Dec, 21 | 6 | -25.00% |
| 30 Sep, 21 | 8 | 33.33% |
| 30 Jun, 21 | 6 | - |
| 31 Mar, 21 | - | - |
1 institutional shareholders have reduced their position in PHVS stock as of 30 Jun 24 compared to 9 in the previous quarter (a -88.89% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 3 | -91.43% | 718,574 | -98.31% | 1.34% | 0.02% | 1 | -94.44% | 1 | -88.89% |
| 31 Mar, 24 | 35 | -2.78% | 42,425,740 | 4.12% | 81.14% | 0.82% | 18 | -40.00% | 9 | 125.00% |
| 31 Dec, 23 | 36 | 71.43% | 40,745,703 | 40.18% | 99.60% | 1.96% | 30 | 233.33% | 4 | -33.33% |
| 30 Sep, 23 | 21 | - | 29,067,102 | 0.53% | 71.20% | 0.97% | 9 | -18.18% | 6 | 50.00% |
| 30 Jun, 23 | 21 | - | 28,913,752 | 32.74% | 85.48% | 2.06% | 11 | 120.00% | 4 | -20.00% |
| 31 Mar, 23 | 21 | -16.00% | 21,781,494 | 2.25% | 64.40% | 1.60% | 5 | -64.29% | 5 | 66.67% |
| 31 Dec, 22 | 25 | 19.05% | 21,301,855 | -4.54% | 63.42% | 1.45% | 14 | 75.00% | 3 | -40.00% |
| 30 Sep, 22 | 21 | 5.00% | 22,314,956 | -0.17% | 66.05% | 1.49% | 8 | - | 5 | -16.67% |
| 30 Jun, 22 | 20 | -9.09% | 22,353,338 | 3.08% | 66.56% | 1.55% | 8 | 33.33% | 6 | -25.00% |
| 31 Mar, 22 | 22 | - | 21,685,388 | 0.18% | 65.44% | 1.53% | 6 | -14.29% | 8 | 33.33% |
| 31 Dec, 21 | 22 | -12.00% | 21,647,018 | 0.07% | 65.33% | 0.76% | 7 | -12.50% | 6 | -25.00% |
| 30 Sep, 21 | 25 | -10.71% | 21,631,651 | -1.66% | 92.91% | 0.50% | 8 | -27.27% | 8 | 33.33% |
| 30 Jun, 21 | 28 | -15.15% | 21,995,815 | -0.13% | 136.16% | 0.23% | 11 | -66.67% | 6 | - |
| 31 Mar, 21 | 33 | - | 22,025,122 | - | 241.91% | - | 33 | - | - | - |
Pharvaris Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| JANX | Janux Therapeutics, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| PEPG | PepGen Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| ELYM | Eliem Therapeutics, Inc. |
PHVS Ownership FAQ
Who Owns Pharvaris?
Pharvaris is owned by institutional shareholders (1.34%), insiders (9.49%), and public (89.17%). The largest institutional shareholder of Pharvaris is GENERAL ATLANTIC, L.P. (13.99% of total shares) and the top mutual fund owner is MUTUAL FUND SERIES TRUST (0.00% of total shares).
Who are the major institutional shareholders of Pharvaris?
Pharvaris's major institutional shareholders are GENERAL ATLANTIC, L.P., FMR LLC, FORESITE CAPITAL MANAGEMENT IV, LLC, VENBIO PARTNERS LLC, and VIKING GLOBAL INVESTORS LP. The top five shareholders own together 46.40% of the company's share outstanding.
How many Pharvaris shareholders are there?
As of Jun 2024, there are 3 institutional shareholders of Pharvaris.
What percentage of Pharvaris is owned by GENERAL ATLANTIC, L.P?
GENERAL ATLANTIC, L.P owns 7.53M shares of Pharvaris, representing 13.99% of the company's total shares outstanding, valued at $141.59M (as of Jun 2024).
What percentage of Pharvaris is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 5.21M shares of Pharvaris (PHVS), compromising 9.67% of the company, valued at $97.87M.
What percentage of Pharvaris is owned by FORESITE CAPITAL MANAGEMENT IV, LLC?
FORESITE CAPITAL MANAGEMENT IV, LLC is the third largest holder of Pharvaris. The company owns 4.29M of the company's shares outstanding (worth $80.72M).